Kynam Capital Management, LP
32 holdingsFiling period: 2026-06-30Current AUM: $1.51Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CLDX | Celldex Therapeutics Inc New | 5.32M | $198.1M | $157.0M | 10.40% | -517,659 | 2026-06-30 |
| 2 | SNDX | Syndax Pharmaceuticals Inc | 8.05M | $176.0M | $106.4M | 7.05% | -- | 2026-06-30 |
| 3 | PCVX | Vaxcyte Inc | 2.92M | $169.9M | $175.3M | 11.61% | -- | 2026-06-30 |
| 4 | COGT | Cogent Biosciences Inc | 3.67M | $141.9M | $113.3M | 7.51% | -370,234 | 2026-06-30 |
| 5 | VERA | Vera Therapeutics Inc | 2.89M | $124.0M | $81.8M | 5.42% | -508,165 | 2026-06-30 |
| 6 | VRDN | Viridian Therapeutics Inc | 6.45M | $118.6M | $150.6M | 9.98% | +4.11M | 2026-06-30 |
| 7 | TVTX | Travere Therapeutics Inc | 2.00M | $113.6M | $99.9M | 6.62% | -423,918 | 2026-06-30 |
| 8 | BEAM | Beam Therapeutics Inc | 2.84M | $97.5M | $67.6M | 4.48% | -841,393 | 2026-06-30 |
| 9 | — | Urogen Pharma Ltd | 2.43M | $89.6M | $89.6M | 5.93% | +186.8K | 2026-06-30 |
| 10 | LEGN | Legend Biotech Corp | 3.00M | $86.7M | $61.2M | 4.05% | +1.42M | 2026-06-30 |
| 11 | CTMX | Cytomx Therapeutics Inc. | 21.70M | $81.4M | $48.3M | 3.20% | +6.69M | 2026-06-30 |
| 12 | RLAY | Relay Therapeutics Inc | 3.30M | $61.7M | $59.8M | 3.96% | +1.88M | 2026-06-30 |
| 13 | CGEM | Cullinan Therapeutics Inc | 3.11M | $56.7M | $45.3M | 3.00% | -- | 2026-06-30 |
| 14 | MBX | Mbx Biosciences Inc | 934.8K | $51.6M | $47.0M | 3.11% | -- | 2026-06-30 |
| 15 | IMCR | Immunocore Hldgs PLC | 1.38M | $43.7M | $43.0M | 2.85% | +490.1K | 2026-06-30 |
| 16 | NRIX | Nurix Therapeutics Inc | 1.19M | $29.0M | $30.5M | 2.02% | -- | 2026-06-30 |
| 17 | STRO | Sutro Biopharma Inc | 872.6K | $29.0M | $7.8M | 0.51% | -- | 2026-06-30 |
| 18 | BCRX | Biocryst Pharmaceuticals Inc | 2.52M | $25.2M | $19.9M | 1.32% | -3,158,135 | 2026-06-30 |
| 19 | — | Pharvaris N V | 661.8K | $22.9M | $22.9M | 1.52% | +21.4K | 2026-06-30 |
| 20 | SMMT | Summit Therapeutics Inc | 1.20M | $17.5M | $17.4M | 1.15% | -- | 2026-06-30 |
| 21 | PRLD | Prelude Therapeutics Inc | 2.42M | $12.9M | $8.9M | 0.59% | +822.5K | 2026-06-30 |
| 22 | INSM | Insmed Inc | 100.0K | $10.7M | $9.3M | 0.62% | -- | 2026-06-30 |
| 23 | BNR | Burning Rock Biotech Ltd | 1.24M | $10.5M | $14.0M | 0.93% | +11.0K | 2026-06-30 |
| 24 | GERN | Geron Corp | 6.84M | $8.8M | $7.9M | 0.52% | -- | 2026-06-30 |
| 25 | AMRN | Amarin Corp PLC | 533.0K | $8.5M | $6.4M | 0.43% | +60.6K | 2026-06-30 |
← Scroll →
Page 1 of 2